@article{articlecca33450,
title   = {Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA)},
author = {Schneeweiss, A. and Chia, S. and Hickish, T. and Harvey, V. and Eniu, A. and Hegg, R. and Tausch, C. and Seo, J. H. and Tsai, Y.-F. and Ratnayake, J. and McNally, V. and Ross, G. and Cortés, J.},
year = {2013},
doi = {10.1093/annonc/mdt182},
journal   = {Annals of Oncology}
}